Arrowhead Research | Omløpsmidler

Current Assets Endring Dato
Agios Pharmaceuticals USD 833.83M 129.48M 2023-12
Alnylam Pharmaceuticals USD 2.98B 2.76M 2023-12
Arrowhead Research USD 237.9M 181.62M 2023-12
Incyte USD 4.65B 242.74M 2023-12
Ionis Pharmaceuticals USD 2.64B 57.2M 2023-12
Ligand Pharmaceuticals USD 237.43M 16.56M 2023-12
Merck USD 31.95B 1.98B 2023-09
Moderna USD 10.32B 474M 2023-12
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
TG Therapeutics USD 319.11M 110.54M 2023-09
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09
Xencor USD 623.16M 51.98M 2023-12



Arrowhead Research Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.